verified SJR 1,022 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · John Wiley and Sons Ltd

workspace_premium Q1 — Epidemiology lock_open Open Access

Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety is a journal indexed in SJR in Epidemiology and Pharmacology (medical) with an H index of 113. It has a price of 3750 €. It has an SJR impact factor of 1,022 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,022.

Pharmacoepidemiology and Drug Safety focuses its scope in these topics and keywords: drug, review, regulatory, prescriptions, methods, claims, fda, effects, confounding, children, ...

ISSN: 1053-8569

Publisher: John Wiley and Sons Ltd

Category: Epidemiology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,022 Q1

H-index 113

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.750 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,022

H-index

113

Docs (year)

243

Docs 3y

480

Total refs

7639

Cites 3y

1101

Citable 3y

446

Cites/Doc 2y

2.26

Ref/Doc

31.44

Immediate OA

3750 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Assessments of disproportionality

Variations in antidepressant prescribing practice: clinical need or market influences?

Current awareness: Pharmacoepidemiology and drug safety

Correlated measures in longitudinal analysis of daily drug use patterns in a general intensive care unit

Copayments for prescription medicines on a public health insurance scheme in Ireland

Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States

Clinical judgment, common sense and adverse reaction reporting

Cephalosporin utilization in the inpatient wards of a teaching hospital in Western Nepal

Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry

Attitudes to feedback with drug utilisation 90%(DU90%) profiles among prescribers in Rijeka, Croatia

SHOW MORE ARTICLES

Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink

A framework for describing the impact of antidepressant medications on population health status

Antihypertensive treatment is associated with improved left ventricular geometry: the Rotterdam Study

Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients

Antibiotic use profile at paediatric clinics in two transitional countries

Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians

Analgesic use for postoperative pain: differences arise when comparing departments of surgery

Adverse drug reactions in a South Indian hospital?their severity and cost involved

Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden

A retrospective, study of prescribing for erectile dysfunction in a UK population during 1997-2000: demand was neither excessive nor continuing to rise

A retrospective survey on the safety of Replenine¬Æ, a high-purity factor IX concentrate

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System(VAERS) - United States, 1991-2001,

FAQs

Pharmacoepidemiology and Drug Safety has an SJR of 1,022 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3750 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Pharmacoepidemiology and Drug Safety is 24%.

Pharmacoepidemiology and Drug Safety

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Pharmacoepidemiology and Drug Safety?

What is the APC / publication cost?

What is the acceptance rate?